| Description: |
Dear Colleague,
The Biomarker Summit 2017, to be held on March 20-22, 2017 in San Diego, CA at the Hilton San Diego Resort & Spa, is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization.
A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.
Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in four major therapeutic areas, formally organized in the following tracks:
General Session:
- Plenary Keynote Session
- Big Data Analytics & Bioinformatics for Biomarkers Development
- Emerging Technologies in Biomarker Development
- Overcoming Challenges of Clinical Validation & Translation
- Panel Discussion: Companion Diagnostics Development & Partnering Strategies
- Overcoming Commercialization Challenges in Biomarker Development
-Regulatory & Reimbursement Trends in Biomarker Development
-Current Landscape of Biomarkers IP & Future Trends
10th Oncology Biomarkers
- Circulating Tumor Cells & Microvesicles
- Liquid Biopsy: Circulating DNA & MicroRNA
- Immuno-oncology Biomarkers
- Novel Technologies in Oncology Biomarkers
6th Neurological Biomarkers
- Imaging Approaches in CNS Drug Discovery & Development
- CSF & Blood Based Biomarker Approaches
- Monitoring Progression in Neurodegenerative Disorders
- Novel Technologies in Neurological Biomarkers
6th Inflammatory & Immunological Biomarkers
- Biomarkers of Early Progressive Inflammatory & Immunological Diseases
- Biomarkers & Surrogate Endpoints for Clinical Trials in Inflammatory Diseases
- Microbiomes in Immune Modulation & Inflammatory Diseases
- Inflammatory Biomarkers in Respiratory Diseases
Cardiovascular Biomarkers
- Biomarker R&D in the Cardiovascular Space
- Heart Failure & Acute Coronary Syndromes
- Metabolic Syndrome & Cardiovascular Risk
- Novel Technologies in Cardiovascular Biomarkers
Best regards,
The 2017 Advisory Committee |